Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.

about

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.

P2860

Q33832740-E4BEBA28-E9E3-49E6-8EDD-21C561EC39E1 Q33843533-1AE789FF-BEF2-4EF9-A287-CE53D9444DF8

P2860

Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.

Item

http://www.wikidata.org/entity/Q48037262

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Health-related quality-of-life ...... d clinical trials in oncology.

@en

Health-related quality-of-life ...... d clinical trials in oncology.

@nl

type

Item

label

Health-related quality-of-life ...... d clinical trials in oncology.

@en

Health-related quality-of-life ...... d clinical trials in oncology.

@nl

prefLabel

Health-related quality-of-life ...... d clinical trials in oncology.

@en

Health-related quality-of-life ...... d clinical trials in oncology.

@nl

P1476

Health-related quality-of-life ...... d clinical trials in oncology.

@en

P2093

Alhousseiny Pam

http://www.w3.org/2001/XMLSchema#string

Amélie Anota

http://www.w3.org/2001/XMLSchema#string

Dewi Vernerey

http://www.w3.org/2001/XMLSchema#string

Franck Bonnetain

http://www.w3.org/2001/XMLSchema#string

Frédéric Fiteni

http://www.w3.org/2001/XMLSchema#string

Sophie Paget-Bailly

http://www.w3.org/2001/XMLSchema#string

Virginie Westeel

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

P304

885-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2015.1047768

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277602854

http://www.w3.org/2001/XMLSchema#string

P698

26027598

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.

about

P2860

P2860

Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921